In addition, BEVs can deliver transforming growth factor-beta (TGF-β), which suppresses cytotoxic T-cell function and promotes the expansion of regulatory T-cells (Tregs) in the tumor microenvironment [89]. The gene discussed is TGFB1; the disease is neoplasm.